These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3019745)

  • 41. A reproducible colonial morphology formed by individual pluripotent embryonal carcinoma cells in culture and selection of variants.
    Cotton RG
    Differentiation; 1982; 22(3):211-7. PubMed ID: 7173530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compaction-defective embryonal carcinoma cell variants.
    Littlefield JW
    Dev Genet; 1989; 10(4):292-7. PubMed ID: 2791350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
    Damjanov I; Horvat B; Gibas Z
    Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in surface glycoconjugates in adhesion-defective variants of P19 embryonal carcinoma cells.
    Sakalian M; Dráber P
    Int J Dev Biol; 1991 Dec; 35(4):473-9. PubMed ID: 1666295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stimulation of the clonal growth and differentiation of feeder layer dependent mouse embryonal carcinoma cells by beta-mercaptoethanol.
    Oshima R
    Differentiation; 1978; 11(3):149-55. PubMed ID: 720785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic cooperation in vitro: differential ability of ouabain to uncouple normal, preneoplastic, and neoplastic mouse mammary cells.
    Miller FR; McInerney D; Miller BE
    Biochem Biophys Res Commun; 1986 Nov; 140(3):955-61. PubMed ID: 3778494
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular analysis of early growth-associated events during the differentiation of F9 cells into embryoid bodies.
    Whitman MM; Shen YM; Soprano D; Soprano KJ
    Cancer Res; 1990 Jun; 50(11):3193-8. PubMed ID: 2139801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multipotent mutator strain of mouse teratocarcinoma cells.
    Aizawa S; Ohashi M; Loeb LA; Martin GM
    Somat Cell Mol Genet; 1985 May; 11(3):211-6. PubMed ID: 3859019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Appearance of nuclear protease activity after embryonal carcinoma cells undergo differentiation.
    Scholtz B; Lamb K; Rosfjord E; Kingsley M; Rizzino A
    Dev Biol; 1996 Feb; 173(2):420-7. PubMed ID: 8606002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue-specific activation of a cloned alpha-fetoprotein gene during differentiation of a transfected embryonal carcinoma cell line.
    Scott RW; Vogt TF; Croke ME; Tilghman SM
    Nature; 1984 Aug 16-22; 310(5978):562-7. PubMed ID: 6205280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell interactions and endoderm differentiation in cultured mouse embryos.
    Hogan BL; Tilly R
    J Embryol Exp Morphol; 1981 Apr; 62():379-94. PubMed ID: 7276820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new differentiated cell line (Dif 5) derived by retinoic acid treatment of F9 teratocarcinoma cells capable of extracellular matrix production and growth in the absence of serum.
    Nagarajan L; Jetten AM; Anderson WB
    Exp Cell Res; 1983 Sep; 147(2):315-27. PubMed ID: 6193979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone morphogenetic proteins-2 and -4 are involved in the retinoic acid-induced differentiation of embryonal carcinoma cells.
    Rogers MB; Rosen V; Wozney JM; Gudas LJ
    Mol Biol Cell; 1992 Feb; 3(2):189-96. PubMed ID: 1550961
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abrogation of Gap Junctional Communication in ES Cells Results in a Disruption of Primitive Endoderm Formation in Embryoid Bodies.
    Wörsdörfer P; Bosen F; Gebhardt M; Russ N; Zimmermann K; Komla Kessie D; Sekaran T; Egert A; Ergün S; Schorle H; Pfeifer A; Edenhofer F; Willecke K
    Stem Cells; 2017 Apr; 35(4):859-871. PubMed ID: 27870307
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells.
    Rodrigues M; Balicki D; Newrock KM; Mukherjee BB
    Exp Cell Res; 1985 Jan; 156(1):22-30. PubMed ID: 2981174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of specific protein expression in teratocarcinoma cell aggregates by antibodies affecting cell-cell interactions.
    Maillet L; Buc-Caron MH
    Dev Biol; 1985 Sep; 111(1):1-7. PubMed ID: 2411614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The induction of differentiation in teratocarcinoma stem cells by retinoic acid.
    Strickland S; Mahdavi V
    Cell; 1978 Oct; 15(2):393-403. PubMed ID: 214238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatocytic transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell lines: expression of HNF-3 alpha in models of early endodermal cell differentiation.
    Roach S; Schmid W; Pera MF
    Exp Cell Res; 1994 Nov; 215(1):189-98. PubMed ID: 7957668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BMPs regulate differentiation of a putative visceral endoderm layer within human embryonic stem-cell-derived embryoid bodies.
    Conley BJ; Ellis S; Gulluyan L; Mollard R
    Biochem Cell Biol; 2007 Feb; 85(1):121-32. PubMed ID: 17464352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A heparin binding protein whose expression increases during differentiation of embryonal carcinoma cells to parietal endoderm cells: cDNA cloning and sequence analysis.
    Furukawa T; Ozawa M; Huang RP; Muramatsu T
    J Biochem; 1990 Aug; 108(2):297-302. PubMed ID: 2229028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.